Regulation of Myc driven transcription programs was cited as a consequence of BET inhibition in these tumor models, with BET inhibitors directly silencing MYC gene expression via disruption of BET protein binding at the MYC locus [11,16–18]. This evidence concerns the gene DNER and neoplasm.